Home › Funds › Privium Fund Management B.V. › PRQR
Privium Fund Management B.V. position in PRQR
PROQR THRAPEUTICS N V · Health Care
Privium Fund Management B.V. reported holding 5,467,149 shares of PRQR (PROQR THRAPEUTICS N V) in its Q3 2026 13F filing — a position valued at US$9.1M, representing 1.76% of its reported portfolio and ranking #17 among its reported holdings. Privium Fund Management B.V. has disclosed PRQR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Privium Fund Management B.V.'s PRQR position evolved
Privium Fund Management B.V. first disclosed a stake in PRQR in Q3 2023 at 5,344,446 shares (US$6.9M). The position peaked in Q4 2024 at 4,985,633 shares, worth US$13.2M. Across 13 filings, Privium Fund Management B.V. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 5,467,149 shares valued at US$9.1M — a reduction of -52,875 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.34M | $6.95M | New |
| Q4 2023 | 5.34M | $11.12M | Hold |
| Q1 2024 | 5.34M | $12.24M | Hold |
| Q2 2024 | 5.58M | $9.21M | Add |
| Q3 2024 | 5.63M | $10.25M | Add |
| Q4 2024 | 4.99M | $13.21M | Reduce |
| Q1 2025 | 4.99M | $6.63M | Hold |
| Q2 2025 | 5.00M | $10.05M | Hold |
| Q3 2025 | 5.00M | $10.65M | Hold |
| Q4 2025 | 5.36M | $10.82M | Add |
| Q1 2026 | 5.47M | $8.86M | Add |
| Q2 2026 | 5.52M | $10.27M | Add |
| Q3 2026 | 5.47M | $9.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRQR and 13F data
PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 37 other funds we track also report a position in PRQR — the largest reported positions include Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M), Kynam Capital Management, LP (US$2.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRQR
- Ikarian Capital, LLC 3.43M sh · $6.37M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 2.76M sh · $5.14M · Q2 2026
- Kynam Capital Management, LP 1.57M sh · $2.91M · Q2 2026
- DAFNA Capital Management LLC 1.53M sh · $2.85M · Q2 2026
- Squadron Capital Management LLC 1.51M sh · $2.81M · Q2 2026
- M28 Capital Management LP 599.79K sh · $1.12M · Q2 2026
- Monaco Asset Management SAM 634.92K sh · $1.05M · Q3 2026
- Lynx1 Capital Management LP 521.41K sh · $969.83K · Q2 2026
More on Privium Fund Management B.V.
FAQ
How long has Privium Fund Management B.V. held PRQR?
Privium Fund Management B.V. has disclosed PRQR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Privium Fund Management B.V.'s current position in PRQR?
As of Q3 2026, Privium Fund Management B.V. holds 5.47M shares of PRQR (PROQR THRAPEUTICS N V), valued at $9.08M, representing 1.76% of its reported portfolio and ranking #17.
Has Privium Fund Management B.V. been buying or selling PRQR?
In the latest 13F filing (Q3 2026), Privium Fund Management B.V. reduced its position in PRQR. The position peaked in Q4 2024 at 4.99M shares.
Which other funds hold PRQR?
Other major institutional holders of PRQR include Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, Kynam Capital Management, LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.